Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-12-039670
Filing Date
2012-07-16
Accepted
2012-07-16 17:12:32
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A v318582_10ka.htm 10-K/A 1276839
2 EXHIBIT 31.1 v318582_ex31-1.htm EX-31.1 11689
3 EXHIBIT 31.2 v318582_ex31-2.htm EX-31.2 11804
4 EXHIBIT 32.1 v318582_ex32-1.htm EX-32.1 6346
11 GRAPHIC pg31.jpg GRAPHIC 12425
  Complete submission text file 0001144204-12-039670.txt   3431263

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001420030-20111231_pre.xml EX-101.PRE 135221
6 XBRL TAXONOMY EXTENSION SCHEMA ck0001420030-20111231.xsd EX-101.SCH 15286
7 XBRL INSTANCE DOCUMENT ck0001420030-20111231.xml EX-101.INS 331464
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001420030-20111231_cal.xml EX-101.CAL 44635
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001420030-20111231_def.xml EX-101.DEF 112951
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001420030-20111231_lab.xml EX-101.LAB 148536
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Filer) CIK: 0001420030 (see all company filings)

EIN.: 205863618 | Fiscal Year End: 1209
Type: 10-K/A | Act: 34 | File No.: 000-53071 | Film No.: 12964231
SIC: 6770 Blank Checks